Using a new device to treat lung cancer with targeted radiation

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study evaluates the effectiveness of the CivaSheet, a brachytherapy device that uses palladium-103, in treating non-small cell lung cancer (NSCLC) located in the upper lobes of the lungs. The approach aims to deliver a therapeutic radiation dose to cancerous tissues while minimizing exposure to surrounding critical structures, such as the heart. Patients with lung nodules suspicious for NSCLC and specific size criteria will be included in the study. The goal is to assess the device's safety and efficacy in a clinical setting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subject signed inform consent
* Suspected or proven non-small cell lung cancer (NSCLC) in the upper lobes of the left or right lung
* Pre-operative criteria
* Lung nodule suspicious for NSCLC
* Mass ≤ 7 cm in maximum diameter by CT scan of the chest and upper abdomen
* Clinical stage I or Clinical stage II
* Not pregnant or nursing
* Negative pregnancy test in premenopausal women
* Fertile patients must use effective contraception
* More than 5 years since prior invasive malignancy unless non melanoma skin cancer or in-situ cancer

Exclusion Criteria:

\-

Where it's running

• NYU Langone Health
  New York, New York, United States Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Microwave ablation for treating lung cancer nodules

  This study is testing a new microwave treatment for destroying small lung cancer nodules to see if it is safe and effective for patients.

  Recruiting Beth Israel Deaconess Medical Center · Boston, Massachusetts · NCT05281237

• Registry for individuals diagnosed with lung cancer

  This study is collecting information from people with stage I lung cancer who are having surgery to see how they feel before and after the procedure to improve future treatments and care.

  Recruiting at 20 sites Memorial Sloan Kettering Cancer Center · Tucson, Arizona and 19 other locations · NCT06424327

• Combining Certolizumab with Chemotherapy and Nivolumab for Treating Lung Cancer

  This study is testing if adding certolizumab to regular chemotherapy and nivolumab can help people with operable stage II-III lung cancer feel better by reducing inflammation and improving treatment results.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT04991025

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.